课题基金 / 基金详情

Study on the molecular mechanism of alveolus bone resorption induced periodontal diseases

Study on the molecular mechanism of alveolus bone resorption induced periodontal diseases
牙槽骨吸收诱发牙周病的分子机制研究
批准号:
16390535
负责人:
TAKAHASHI Naoyuki
金额:
$9.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

TAKAHASHI Naoyuki的其他基金

相似基金

相关文献

中文摘要
翻译
“利用双杂交系统鉴定TRAF6相互作用分子”、“牙周病动物模型的建立”、“利用动物模型建立牙周病的治疗方法”等研究项目目前正在我室进行。其他研究结果如下:1.利用MyD88基因缺陷小鼠和TRIF基因缺陷小鼠,内毒素和IL-1诱导的成骨细胞RANKL的表达只需要MyD88信号,而不需要TRIF信号。2.Nod2参与了MDP的胞内受体S诱导的成骨细胞RANKL的表达。3.PGE_2直接作用于小鼠破骨祖细胞,促进其向破骨细胞的分化。另一方面,当EP4被转导入破骨细胞后,如降钙素一样,PGE_2通过cAMP-PKA信号抑制破骨细胞的凹坑形成活性。4.建立体外培养的人破骨细胞形成体系,并检测降钙素对破骨细胞的影响。降钙素诱导的人破骨细胞功能需要PKA和PKC两种信号。此外,前列腺素E_2强烈抑制人破骨细胞前体细胞向破骨细胞的分化。前列腺素E_2刺激破骨细胞前体细胞产生抑制因子(S),并抑制其向破骨细胞的分化。5.利用OPG缺陷小鼠和RANKL缺陷小鼠,我们检测了骨形态发生蛋白2(BMP-2)诱导的异位骨中破骨细胞的形成。研究表明,成骨细胞为RANKL的作用提供了关键的微环境。
英文摘要
The research projects "Identification of the TRAF6 interacting molecules by using the two-hybrid system", "Establishments of animal models for periodontal diseases", and "Development of the treatment method for periodontal diseases using the animal models" are currently performed in our laboratory. The results of the other projects were as follows.1.Using MyD88 deficient mice and TRIF deficient mice, the RANKL expression induced by LPS and IL-1 in osteoblasts required only the MyD88 signals but not TRIF signals2.Nod2 is s involved in RANKL expression in osteoblasts induced by muramyl dipeptide (MDP), a component of peptidoglycan, as an intracellular receptor for MDP.3.PGE_2 directly acts on murine osteoclast progenitors and enhances their differentiation into osteoclasts induced by RANKL. On the other hand, when EP4 was transduced into osteoclasts, like calcitonin, PGE_2 inhibited pit-forming activity of osteoclasts through cAMP-PKA signals.4.In vitro culture systems for human osteoclast formation was established, and effects of calcitonin on human osteoclasts were examined. Both PKA- and PKC-mediated signals were required for the calcitonin-induced human osteoclast function. In addition, PGE_2 strongly inhibits the differentiation of human osteoclast progenitors into osteoclasts. PGE_2 stimulates the production of an inhibitory factor(s) by human osteoclast progenitors, and inhibits their differentiation into osteoclasts.5.Using OPG deficient mice and RANKL deficient mice, we examined osteoclast formation in ectopic bone induced by bone morphogenetic protein 2 (BMP-2). It was shown that osteoblasts provide the critical microenvironment for the action of RANKL.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
Osteoblasts provide a suitable microenvironment for the action of receptor activator of NF-κB ligand
成骨细胞为 NF-κB 配体受体激活剂的作用提供合适的微环境
DOI: --
发表时间: 2006
期刊: Endocrinology (In Press)
影响因子: --
作者: [Ohno-Matsui K, Ichinose S, Nakahama K, Yoshida T, Kojima A, Mochizuki M, Morita I, Yamamoto Y.]
通讯作者: Yamamoto Y.
Cyclic AMP/protein kinase A signals enhance osteoclastic differentiation through TAK1 in osteoclast precursors.
环 AMP/蛋白激酶 A 信号通过破骨细胞前体中的 TAK1 增强破骨细胞分化。
DOI: --
发表时间: 2005
期刊: J Biol Chem (in press)
影响因子: --
作者: [Mizoguchi T et al., Kobayashi Y et al.]
通讯作者: Kobayashi Y et al.
Nurse-like cells from patients with rheumatoid arthritis support survival of osteoclast precursors via macrophage-colony stimulating factor production.
来自类风湿性关节炎患者的护士样细胞通过巨噬细胞集落刺激因子的产生支持破骨细胞前体的存活。
DOI: --
发表时间: 2005
期刊: Arthritis Rheum 52・12
影响因子: --
作者: [Nakamichi Y et al., Tsukiyama K et al., Itoh S et al., Yamamoto Y et al., Udagawa N et al., Okumura S et al., Nakamichi Y et al., Tsukiyama K et al., Itoh S et al., Yamamoto Y et al., Udagawa N et al., Okumura S et al., Takahashi N et al., Yamaki M, Kobayashi Y, Kobayashi Y, Yang S, Take I, Tsuboi H]
通讯作者: Tsuboi H
DOI: 10.1074/jbc.m500926200
发表时间: 2005-06-24
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Kobayashi, Y, Take, I, Takahashi, N]
通讯作者: Takahashi, N
21
    Do carbon nanotubes control bone remodeling?
    • 批准号:
      24659833
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    Role of Wnt-Ror2 signals in ruffled border formation in osteoclasts
    • 批准号:
      22659339
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.04万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    Analysis of osteoclast niche regulated by Wnt signals.
    • 批准号:
      22390351
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2010
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    The relationship between cell proliferation and RANKL-induced osteoclastogenesis
    • 批准号:
      18390495
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.15万
    • 财政年份:
      2006
    • 负责人:
      TAKAHASHI Naoyuki
    • 依托单位:
    国内基金
    海外基金
    Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
    • 批准号:
      82370979
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      张善勇
    • 依托单位:
    仿生膜构建破骨细胞融合纳米诱饵用于骨质疏松治疗的研究
    • 批准号:
      82372098
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      倪大龙
    • 依托单位:
    组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
    • 批准号:
      82370988
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      经典
    • 依托单位:
    先天型成骨不全骨量失衡的病理机制及动物模型的研究
    • 批准号:
      30973070
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2009
    • 负责人:
      张浩
    • 依托单位: